l General Information |
Product Name | Verdinexor (KPT-335) |
General description | Verdinexor (KPT-335) is an orally bioavailable, selective XPO1/CRM1 inhibitor. |
Synonym | (Z)-3-[3-[3,5-bis(trifluoromethyl)phenyl]-1,2,4-triazol-1-yl]-N'-pyridin-2-ylprop-2-enehydrazide |
Purity | ≥98.5%(HPLC) | CAS Number | 1392136-43-4 |
Formula | C18H12F6N6O | Molecular Weight | 442.32 |
Suitability | BioReagent, suitable for cell culture, etc. |
l Physical and Chemical Information |
Appearance | Solid |
Solubility(25°C) | DMSO | ≥50mg/ml |
Ethanol | ≥5mg/ml |
Water | Very slightly soluble |
l Storage |
Storage temp. | -20°C |
l Precautions and Disclaimer |
This product is for R&D use only, not for drug, household, or other uses. |
l References |
1. http://www.drugbank.ca 2. https://ncit.nci.nih.gov 3. https://www.ncbi.nlm.nih.gov |
